Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

726 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients.
Martino R, Subirá M, Rovira M, Solano C, Vázquez L, Sanz GF, Urbano-Ispizua A, Brunet S, De la Cámara R; alloPBSCT Infectious/Non-infectious Complications Subcommittees of the Grupo Español de Trasplante Hematopoyético (GETH). Martino R, et al. Among authors: brunet s. Br J Haematol. 2002 Feb;116(2):475-82. doi: 10.1046/j.1365-2141.2002.03259.x. Br J Haematol. 2002. PMID: 11841455 Free article.
Lack of influence of human immunodeficiency virus infection status in the response to therapy and survival of adult patients with mature B-cell lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study.
Oriol A, Ribera JM, Esteve J, Sanz MA, Brunet S, Garcia-Boyero R, Fernández-Abellán P, Martí JM, Abella E, Sánchez-Delgado M, Peñarrubia MJ, Besalduch J, Moreno MJ, Borrego D, Feliu E, Ortega JJ; PETHEMA Group, Spanish Society of Hematology. Oriol A, et al. Among authors: brunet s. Haematologica. 2003 Apr;88(4):445-53. Haematologica. 2003. PMID: 12681972 Clinical Trial.
Strategies to reduce transplant-related mortality after allogeneic stem cell transplantation in elderly patients: Comparison of reduced-intensity conditioning and unmanipulated peripheral blood stem cells vs a myeloablative regimen and CD34+ cell selection.
Canals C, Martino R, Sureda A, Altés A, Briones J, Subirá M, Ancín I, Martín-Henao G, Brunet S, Sierra J. Canals C, et al. Among authors: brunet s. Exp Hematol. 2003 Nov;31(11):1039-43. doi: 10.1016/s0301-472x(03)00223-6. Exp Hematol. 2003. PMID: 14585367 Free article.
Feasibility and results of autologous stem cell transplantation in de novo acute myeloid leukemia in patients over 60 years old. Results of the CETLAM AML-99 protocol.
Oriol A, Ribera JM, Esteve J, Guàrdia R, Brunet S, Bueno J, Pedro C, Llorente A, Tormo M, Besalduch J, Sánchez JM, Batlle M, Vivancos P, Carreras E, Vilà JM, Julià A, Sierra J, Montserrat E, Feliu E; CETLAM AML-99. Oriol A, et al. Among authors: brunet s. Haematologica. 2004 Jul;89(7):791-800. Haematologica. 2004. PMID: 15257930 Clinical Trial.
Treatment of primary acute myeloid leukemia: results of a prospective multicenter trial including high-dose cytarabine or stem cell transplantation as post-remission strategy.
Brunet S, Esteve J, Berlanga J, Ribera JM, Bueno J, Martí JM, Bargay J, Guardia R, Juliá A, Granena A, Montserrat E, Sierra J; Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias. Brunet S, et al. Haematologica. 2004 Aug;89(8):940-9. Haematologica. 2004. PMID: 15339677 Clinical Trial.
726 results